Financials
- Market Capitalization 1.8 B
- Employee 975
- Founded 2007
- CEO N/A
- Website www.iovance.com
- Headquarter Delaware, United States
- FIGI BBG000FTLBV7
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-2.5
売上高対価格比率
0
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2065 | ZYME Zymeworks Inc. - Common Stock | 24.94 USD | -3.63% | -1.81% | +8.34% | +40.59% | 1.82 B USD | ||
| 2066 | NTLA Intellia Therapeutics, Inc. - Common Stock | 13.02 USD | -8.44% | -27.06% | +1.88% | -5.10% | 1.82 B USD | ||
| 2088 | ZBIO Zenas BioPharma, Inc. - Common Stock | 27.88 USD | -2.99% | +5.25% | +35.27% | +5.37% | 1.76 B USD | ||
| 2093 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.30 USD | -7.30% | -16.46% | 0.00% | -37.85% | 1.75 B USD |